. 2017 Apr 18;15(2):83–93. doi: 10.1016/j.aju.2017.03.005

Table 2.

Results of the 10 included studies.

Reference	Treatment vs control	Expulsion rate, n/N	Expulsion time, days, mean (SD) unless otherwise specified	Standard therapy	Re-hospitalisation, n/N	Side-effects
Al-Ansari et al. [25]	Tamsulosin	41/50	6.4 (2.77)	Diclofenac		1 retrograde ejaculation and 1 hypotension in tamsulosin group. Dizziness and headache 2 each in each group. 1 rhinitis in tamsulosin group. Fatigue 2 in tamsulosin group and 1 in control group
Al-Ansari et al. [25]	Control	28/46	9.87 (5.4)
Furyk et al. [26]	Tamsulosin	140/161	Median 7	Indomethacin, oxycodone	20/198 23/193	Dizziness, tamsulosin 46, control 36; Palpitations, tamsulosin 13, control 14; Collapse, tamsulosin 3, control 2; Sexual dysfunction, tamsulosin 13, control 5; Headache, tamsulosin 50, control 56; Fatigue, tamsulosin 55, control 47; Nausea, tamsulosin 53, control 55; Vomiting, tamsulosin 14, control 18; Diarrhoea, tamsulosin 23, control 22; Constipation tamsulosin 36, control 28
Furyk et al. [26]	Control	127/155	Median 11		20/198 23/193
Hermanns et al. [27]	Tamsulosin	39/45	Median 7	Diclofenac, metamizole	6/45 2/45	Tamsulosin group: 1 diarrhoea, 1 cutaneous reaction, 2 retrograde ejaculation Placebo group: 1 dizziness
Hermanns et al. [27]	Control	40/45	Median 10		6/45 2/45
Ochoa-Gomez et al. [28]	Tamsulosin	22/32	22 (6.77)	Not specified		Tamsulosin group: 2 dizziness 2 retrograde ejaculation
Ochoa-Gomez et al. [28]	Placebo	23/33	23 (6.36)			Tamsulosin group: 2 dizziness 2 retrograde ejaculation
Pedro et al. [29]	Alfuzosin	25/34	5.2 (4.82)	None		Alfuzosin 4 patients with dizziness and hypotension and stopped treatment. Nil in placebo
Pedro et al. [29]	Control	27/35	8.5 (6.99)
Pickard et al. [30]	Tamsulosin	307/378	16.5 (12.6), 79 patients	Not clear		Nifedipine 1 with diarrhoea, pain and vomiting, 1 with malaise, headache and chest pain. 1 with chest pain. Placebo 1 with headache, pain, light-headedness
	Nifedipine	304/379	16.2 (14.5), 74 patients
	Control	303/379	15.9 (11.3), 84 patients
	Control	22/30	–
Sameer et al. [31]	Alfuzosin	30/35	12 (6.67)	Diclofenac, tramadol	5/35 11/35 27/35	Alfuzosin 3 retrograde ejaculation Nifedipine 1 hypotension
	Nifedipine	21/35	12 (6.69)
	Control	7/35	12.29 (9.46)
Sur et al. [32]	Silodosin	60/115	–	Oxycodone		Retrograde ejaculation, silodosin 11, control 1; Nausea, silodosin 9, control 2; Dizziness, silodosin 8, control 2; Headache, silodosin 4, control 0; Vomiting, silodosin 4, control 4; Constipation, silodosin 3, control 2; Nasal congestion, silodosin 3, control 0; Diarrhoea, silodosin 2, control 3
Sur et al. [32]	Control	52/117	–
Vincendeau et al. [33]	Tamsulosin	47/61	10.1 (10)	Ketoprofen and phloroglucinol	4/61 6/61	Headache, placebo 7 tamsulosin 7; Asthenia, placebo 18 tamsulosin 21; Orthostatic hypotension, placebo 3 tamsulosin 6; Palpitation, placebo 1 tamsulosin 3; Nausea or vomiting, placebo 7 tamsulosin 12; Other gastrointestinal disorder, placebo 10 tamsulosin 16; Retrograde ejaculation, tamsulosin 4; Skin reaction placebo 1
Vincendeau et al. [33]	Placebo	43/61	9.6 (9.8)		4/61 6/61
Wang et al. [34]	Silodosin	48/62	6.31 (2.13)	Ketoroalic and buprenorphine	0/62 0/61	Silodosin 10, placebo 2: asthenia; hypotension; palpitation; syncope
Wang et al. [34]	Placebo	33/61	9.73 (2.76)		0/62 0/61